Delivery Order SPE2DB22D2005-SPE2DB24FJJK4
Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $22K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The $15,883.20 contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has been awarded numerous pharmaceutical and medical supply contracts by DLA to support military...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $31,766.40 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will deliver the pharmaceutical items to support military...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical product. The firm fixed price contract has a ceiling value of $10,256.38 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,740.78, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of January 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,343.13, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.S0ML, a vaccine product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 17, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,792.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. This award is under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to deliver...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,081.46, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,813.72, is a delivery order for the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML product. It has an ultimate completion date of March 4, 2025 and a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order (SPE2DB20D2014|SPE2DB24FB28J) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This $2,840.23 award has an ultimate completion date of March 11, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025 to deliver a wide range of pharmaceutical products and...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,602.34, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. This is a Firm Fixed Price Delivery Order contract with a completion date of May 9, 2024. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999...